Venus Remedies informs about press release

07 Jun 2023 Evaluate

Venus Remedies  has informed that it enclosed a press release being issued by the Company today titled ‘Venus Remedies Awarded Ukrainian GMP Approval for Its Carbapenem, Oncology Parenteral Facilities’.

The above information is a part of company’s filings submitted to BSE.

Venus Remedies Share Price

322.00 33.75 (11.71%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.